2009
DOI: 10.1097/qai.0b013e3181967602
|View full text |Cite
|
Sign up to set email alerts
|

National Expansion of Antiretroviral Treatment in Thailand, 2000-2007: Program Scale-Up and Patient Outcomes

Abstract: National ARV treatment programs can be scaled up rapidly with good patient outcomes. Treatment outcomes among patients in Thailand are comparable to those reported in smaller cohorts in other countries, and survival rates have improved since 2004.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
38
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(46 citation statements)
references
References 11 publications
5
38
2
Order By: Relevance
“…By contrast, 18 cohorts containing 39,536 patients in sub-Saharan Africa had median CD4 cell counts typically in the range of 100–150 cells/μl [70], similar to cohorts in Latin America and the Caribbean [71]. However, the median CD4 cell count among 58,000 patients starting ART in Thailand between 2000 and 2005 was just 41 cells/μl [72]. …”
Section: Prevention: Clinical Interventionsmentioning
confidence: 99%
“…By contrast, 18 cohorts containing 39,536 patients in sub-Saharan Africa had median CD4 cell counts typically in the range of 100–150 cells/μl [70], similar to cohorts in Latin America and the Caribbean [71]. However, the median CD4 cell count among 58,000 patients starting ART in Thailand between 2000 and 2005 was just 41 cells/μl [72]. …”
Section: Prevention: Clinical Interventionsmentioning
confidence: 99%
“…Even after stavudine for newly treated patients is being phased out according to WHO's recommendation, this combination is still widely used in these settings. In Thailand, the fixed-dose generic combination antiretroviral drug, GPOvir® (d4T,3TC and NVP), has been universally available since 2002 [2]. The efficacy of GPOvir® and survival benefit has been demonstrated [2],[3].…”
Section: Introductionmentioning
confidence: 99%
“…In Thailand, the fixed-dose generic combination antiretroviral drug, GPOvir® (d4T,3TC and NVP), has been universally available since 2002 [2]. The efficacy of GPOvir® and survival benefit has been demonstrated [2],[3]. Despite of the increased access to ART, adverse effects compelled patients to discontinue or modify the regimen more frequently than ART treatment failure.…”
Section: Introductionmentioning
confidence: 99%
“…4,5 High mortality rates early in ART have been documented in Africa, 6 the Caribbean, 7 Latin America 7 and south-eastern Asia. 8,9 Consequently, additional interventions are needed to decrease early mortality during ART in low-and middle-income countries.…”
Section: Introductionmentioning
confidence: 99%